164 related articles for article (PubMed ID: 31274040)
1. Clinical applicability of proposed algorithm for identifying individuals at risk for hereditary hematologic malignancies.
Clifford M; Bannon S; Bednar EM; Czerwinski J; Davis J; Dunnington L; Shahrukh Hashmi S; DiNardo CD
Leuk Lymphoma; 2019 Dec; 60(12):3020-3027. PubMed ID: 31274040
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC).
DiNardo CD; Bannon SA; Routbort M; Franklin A; Mork M; Armanios M; Mace EM; Orange JS; Jeff-Eke M; Churpek JE; Takahashi K; Jorgensen JL; Garcia-Manero G; Kornblau S; Bertuch A; Cheung H; Bhalla K; Futreal A; Godley LA; Patel KP
Clin Lymphoma Myeloma Leuk; 2016 Jul; 16(7):417-428.e2. PubMed ID: 27210295
[TBL] [Abstract][Full Text] [Related]
3. Practical considerations for diagnosis and management of patients and carriers.
Niemeyer CM; Mecucci C
Semin Hematol; 2017 Apr; 54(2):69-74. PubMed ID: 28637619
[TBL] [Abstract][Full Text] [Related]
4. Frequency of hematologic and solid malignancies in the family history of 50 patients with acute myeloid leukemia - a single center analysis.
Sandner AS; Weggel R; Mehraein Y; Schneider S; Hiddemann W; Spiekermann K
PLoS One; 2019; 14(4):e0215453. PubMed ID: 30998723
[TBL] [Abstract][Full Text] [Related]
5. Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults.
Babushok DV; Bessler M; Olson TS
Leuk Lymphoma; 2016; 57(3):520-36. PubMed ID: 26693794
[TBL] [Abstract][Full Text] [Related]
6. Clinical implementation of genetic testing in adults for hereditary hematologic malignancy syndromes.
Ansar S; Malcolmson J; Farncombe KM; Yee K; Kim RH; Sibai H
Genet Med; 2022 Nov; 24(11):2367-2379. PubMed ID: 36112138
[TBL] [Abstract][Full Text] [Related]
7. Approach Toward Germline Predisposition Syndromes in Patients with Hematologic Malignancies.
Atluri H; Gerstein YS; DiNardo CD
Curr Hematol Malig Rep; 2022 Dec; 17(6):275-285. PubMed ID: 36279069
[TBL] [Abstract][Full Text] [Related]
8. [Hereditary haematological malignancies].
Kotmayer L; Kállay K; Bödör C
Magy Onkol; 2020 Mar; 64(1):43-55. PubMed ID: 32181762
[TBL] [Abstract][Full Text] [Related]
9. Hematological Malignancies in Adults With a Family Predisposition.
Bochtler T; Haag GM; Schott S; Kloor M; Krämer A; Müller-Tidow C
Dtsch Arztebl Int; 2018 Dec; 115(50):848-854. PubMed ID: 30722840
[TBL] [Abstract][Full Text] [Related]
10. Assessing patient attitudes toward genetic testing for hereditary hematologic malignancy.
Johnson AQ; Bannon SA; Farach LS; Hyde SM; Hashmi SS; Wagner C; DiNardo CD
Eur J Haematol; 2023 Jan; 110(1):109-116. PubMed ID: 36209474
[TBL] [Abstract][Full Text] [Related]
11. Improving the detection of patients with inherited predispositions to hematologic malignancies using next-generation sequencing-based leukemia prognostication panels.
DiNardo CD; Routbort MJ; Bannon SA; Benton CB; Takahashi K; Kornblau SM; Luthra R; Kanagal-Shamanna R; Medeiros LJ; Garcia-Manero G; M Kantarjian H; Futreal PA; Meric-Bernstam F; Patel KP
Cancer; 2018 Jul; 124(13):2704-2713. PubMed ID: 29682723
[TBL] [Abstract][Full Text] [Related]
12. Cancer predisposition syndromes associated with myeloid malignancy.
Quinn E; Nichols KE
Semin Hematol; 2017 Apr; 54(2):115-122. PubMed ID: 28637615
[TBL] [Abstract][Full Text] [Related]
13. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility of target capture-based panel sequencing in hematological malignancies: A multicenter feasibility study.
Yasuda T; Sanada M; Nishijima D; Kanamori T; Iijima Y; Hattori H; Saito A; Miyoshi H; Ishikawa Y; Asou N; Usuki K; Hirabayashi S; Kato M; Ri M; Handa H; Ishida T; Shibayama H; Abe M; Iriyama C; Karube K; Nishikori M; Ohshima K; Kataoka K; Yoshida K; Shiraishi Y; Goto H; Adachi S; Kobayashi R; Kiyoi H; Miyazaki Y; Ogawa S; Kurahashi H; Yokoyama H; Manabe A; Iida S; Tomita A; Horibe K
Cancer Sci; 2020 Sep; 111(9):3367-3378. PubMed ID: 32619037
[TBL] [Abstract][Full Text] [Related]
15. t(11;16)(q23;p13)/KMT2A-CREBBP in hematologic malignancies: presumptive evidence of myelodysplasia or therapy-related neoplasm?
Xie W; Tang G; Wang E; Kim Y; Cloe A; Shen Q; Zhou Y; Garcia-Manero G; Loghavi S; Hu AY; Wang S; Bueso-Ramos CE; Kantarjian HM; Medeiros LJ; Hu S
Ann Hematol; 2020 Mar; 99(3):487-500. PubMed ID: 32006151
[TBL] [Abstract][Full Text] [Related]
16. Cytogenetic polyclonality in hematologic malignancies.
Johansson B; Billström R; Broberg K; Fioretos T; Nilsson PG; Ahlgren T; Malm C; Samuelsson BO; Mitelman F
Genes Chromosomes Cancer; 1999 Mar; 24(3):222-9. PubMed ID: 10451702
[TBL] [Abstract][Full Text] [Related]
17. Contribution of extended family history in assessment of risk for breast and colon cancer.
Solomon BL; Whitman T; Wood ME
BMC Fam Pract; 2016 Sep; 17(1):126. PubMed ID: 27580697
[TBL] [Abstract][Full Text] [Related]
18. [Genetics of hereditary hematological malignancies].
Takagi M
Rinsho Ketsueki; 2015 Oct; 56(10):1969-77. PubMed ID: 26458435
[TBL] [Abstract][Full Text] [Related]
19. Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology.
Ripperger T; Bielack SS; Borkhardt A; Brecht IB; Burkhardt B; Calaminus G; Debatin KM; Deubzer H; Dirksen U; Eckert C; Eggert A; Erlacher M; Fleischhack G; Frühwald MC; Gnekow A; Goehring G; Graf N; Hanenberg H; Hauer J; Hero B; Hettmer S; von Hoff K; Horstmann M; Hoyer J; Illig T; Kaatsch P; Kappler R; Kerl K; Klingebiel T; Kontny U; Kordes U; Körholz D; Koscielniak E; Kramm CM; Kuhlen M; Kulozik AE; Lamottke B; Leuschner I; Lohmann DR; Meinhardt A; Metzler M; Meyer LH; Moser O; Nathrath M; Niemeyer CM; Nustede R; Pajtler KW; Paret C; Rasche M; Reinhardt D; Rieß O; Russo A; Rutkowski S; Schlegelberger B; Schneider D; Schneppenheim R; Schrappe M; Schroeder C; von Schweinitz D; Simon T; Sparber-Sauer M; Spix C; Stanulla M; Steinemann D; Strahm B; Temming P; Thomay K; von Bueren AO; Vorwerk P; Witt O; Wlodarski M; Wössmann W; Zenker M; Zimmermann S; Pfister SM; Kratz CP
Am J Med Genet A; 2017 Apr; 173(4):1017-1037. PubMed ID: 28168833
[TBL] [Abstract][Full Text] [Related]
20. Inherited thrombocytopenia and platelet disorders with germline predisposition to myeloid neoplasia.
Galera P; Dulau-Florea A; Calvo KR
Int J Lab Hematol; 2019 May; 41 Suppl 1():131-141. PubMed ID: 31069978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
